Rates of serious infectious events and opportunistic infections in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis treated with etanercept or placebo in clinical trials

被引：0
|
作者：
Hamza, S. [1 ]
Chon, Y. [1 ]
Hooper, M. [1 ]
MacPeek, D. [2 ]
Lin, S. [1 ]
机构：
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
[2] Wyeth Pharmaceut, Collegeville, Philadelphia, PA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：171 / 172
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [22] Discontinuation of Methotrexate or TNF Inhibitors in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana M.
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Coombs, Derek
    Liu, Jianzhong
    Anyanwu, Samuel I.
    Lippe, Ralph
    Curtis, Jeffrey R.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (01) : 97 - 112
  • [24] Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Ogdie, Alexis
    de Vlam, Kurt
    McInnes, Iain B.
    Mease, Philip J.
    Baer, Philip
    Lukic, Tatjana
    Gruben, David
    Kwok, Kenneth
    Wang, Cunshan
    Hsu, Ming-Ann
    Maniccia, Anna
    RMD OPEN, 2020, 6 (01):
  • [25] Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Han, Chenglong
    Robinson, Don W.
    Hackett, Monica V.
    Paramore, L. Clark
    Fraeman, Kathy H.
    Bala, Mohan V.
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (11) : 2167 - 2172
  • [26] A QUANTITATIVE ASSESSMENT OF ADHERENCE TO DMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Raghunath, S.
    Dissanayake, K.
    Goldblatt, F.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 17 - 17
  • [27] PATIENT CHARACTERISTICS AND GOLIMUMAB UTILIZATION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS PATIENTS
    Tandon, N.
    Haas, S.
    Bolge, S.
    Gunnarsson, C.
    VALUE IN HEALTH, 2012, 15 (04) : A48 - A48
  • [28] The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
    Furst, Daniel E.
    Kay, Jonathan
    Wasko, Mary Chester
    Keystone, Edward
    Kavanaugh, Arthur
    Deodhar, Atul
    Murphy, Frederick T.
    Magnus, Jeanette H.
    Hsia, Elizabeth C.
    Hsu, Benjamin
    Xu, Stephen
    Rahman, Mahboob U.
    Doyle, Mittie K.
    RHEUMATOLOGY, 2013, 52 (10) : 1845 - 1855
  • [29] EFFECT OF TOFACITINIB ON REDUCING PAIN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ogdie, A.
    de Vlam, K.
    McInnes, I. B.
    Mease, P. J.
    Baer, P.
    Lukic, T.
    Kwok, K.
    Wang, C.
    Hsu, M. -A.
    Maniccia, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 971 - 972
  • [30] DURATION OF SYMPTOMS BEFORE DIAGNOSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Sorensen, J.
    Hetland, M. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 80 - 81
12345